Content about Pioglitazone

March 18, 2011

With respect to the Type 2 diabetes drug Avandia, British drug maker GlaxoSmithKline has another medical study to worry about.

February 2, 2011

Eli Lilly’s and Amylin Pharmaceuticals’ Type 2 diabetes drug, Bydureon, appears to work better at promoting weight loss than drugs made by Takeda and Merck, but it could face a challenger of its own.

January 17, 2011

Japanese drug maker Takeda Pharmaceutical has signed an agreement with Durham, N.C.-based Zinfandel Pharmaceuticals to develop a test for assessing Alzheimer’s disease risk in adults, the two companies said.

December 22, 2010

Takeda and its subsidiary settled the patent suits it brought against generic drug makers that sought to develop their own versions of its diabetes treatment.

September 22, 2010

The Food and Drug Administration has moved to significantly restrict access to a controversial diabetes...

September 16, 2010

The Food and Drug Administration said Friday it had begun a safety review of Takeda’s...

May 11, 2010

Ranbaxy Labs had net sales of $542 million and profits of $210 million in first...

March 15, 2010

Mylan has settled patent litigation cases with Takeda concerning two diabetes drugs, the generic drug...

March 14, 2010

India’s Ranbaxy Labs will launch a generic version of a diabetes drug in two years,...

March 9, 2010

MORRISTOWN, N.J. Watson Pharmaceuticals and Takeda Pharmaceuticals North America have settled a patent litigation case...

February 10, 2010

Women with Type 2 diabetes who take a commonly prescribed class of medications to treat...

© 2014 Drug Store News. All Rights Reserved.